HEALTHY
Aditya Birla Sun Life Nifty Healthcare ETF
Each stock's 10,000-path forecast, rendered as light.
Aditya Birla Sun Life Nifty Healthcare ETF (HEALTHY) Stock Analysis & Case Study
Is HEALTHY a good buy? The data-driven verdict.
on the numbers it worth a closer look, a Downstox Snapshot Score of 61/100.
On the numbers, Aditya Birla Sun Life Nifty Healthcare ETF (HEALTHY) worth a closer look, a Downstox Snapshot Score of 61/100, weighing a 83% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027-2031.
Last updated . Data snapshot for research, not investment advice.
How HEALTHY ranks against the 2,373 companies in our screener
HEALTHY is not currently one of the 2,373 companies in our live screener universe, so no percentile comparison is available for it here.
HEALTHY share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 4.7y of HEALTHY history (14%/yr drift, 15%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| HEALTHY 2027 | ₹16 | ₹20 | ₹24 | +15% |
| HEALTHY 2028 | ₹17 | ₹23 | ₹29 | +31% |
| HEALTHY 2029 | ₹19 | ₹26 | ₹36 | +51% |
| HEALTHY 2030 | ₹21 | ₹30 | ₹43 | +73% |
| HEALTHY 2031 | ₹23 | ₹34 | ₹51 | +98% |
Median (P50) is the central estimate; the P10-P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability HEALTHY goes up, or doubles?
The bull case for HEALTHY
- A 10,000-path probability model puts a 83% chance the price is higher in a year, with a median target of ₹20 (+15%).
- Relatively low volatility (15%/yr), a steadier ride than the typical mid/small-cap.
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹36.
The bear case & risks
- No model or past record guarantees future returns, treat this as one input, not a decision.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹19.
HEALTHY volatility & expected range, how bumpy is the ride?
Over the last 4.7 years HEALTHY compounded at 14%/year with annualized volatility of 15%. That volatility implies a 1-year 80% range of ₹16-₹24, the honest backbone behind any single price target.
HEALTHY price forecast, the full 60-month probability fan
HEALTHY price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds HEALTHY hits common targets within the simulated horizon?
Full multi-horizon detail on the HEALTHY price target & forecast page.
HEALTHY MTF margin & leverage across 6 brokers
Margin Trading Facility lets you buy HEALTHY with part of the capital. Lower margin % = higher leverage. Rates compared across 6 brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| UpstoxCHEAPEST | 26.50% | 3.8× |
| GrowwCHEAPEST | 26.50% | 3.8× |
| DhanCHEAPEST | 26.50% | 3.8× |
| Kotak Neo | 26.53% | 3.8× |
| Paytm MoneyCHEAPEST | 26.50% | 3.8× |
| Anand RathiCHEAPEST | 26.50% | 3.8× |
Compare every broker on the HEALTHY MTF page.
About Aditya Birla Sun Life Nifty Healthcare ETF: sector, index & market-cap context
Aditya Birla Sun Life Nifty Healthcare ETF (HEALTHY) is an NSE-listed company. See more stocks on our screener.
How the HEALTHY Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of Aditya Birla Sun Life Nifty Healthcare ETF's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
HEALTHY analysis, FAQs
Is Aditya Birla Sun Life Nifty Healthcare ETF (HEALTHY) a good buy?
On the numbers, Aditya Birla Sun Life Nifty Healthcare ETF (HEALTHY) worth a closer look, a Downstox Snapshot Score of 61/100, weighing a 83% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is HEALTHY overvalued or undervalued?
Valuation ratios for HEALTHY are tracked live on Downstox.
What is the HEALTHY share price target for 2031?
HEALTHY's probability-weighted 2031 median target is ₹34, with an 80% range of ₹23-₹51 (10,000-path Monte-Carlo).
What is the probability HEALTHY doubles in 5 years?
The modelled probability of HEALTHY reaching ₹34 (2×) within 5 years is 49%.
What is the bull case for HEALTHY?
A 10,000-path probability model puts a 83% chance the price is higher in a year, with a median target of ₹20 (+15%). Relatively low volatility (15%/yr), a steadier ride than the typical mid/small-cap.
What are the risks in HEALTHY?
No model or past record guarantees future returns, treat this as one input, not a decision.